Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Allergy & Immunology
•
Asthma
Do you utilize urinary leukotrienes as a marker for initiation of montelukast?
Answer from: at Academic Institution
No, I don’t. It is not readily available clinically and has not been shown to be predictive of response.
Sign In
or
Register
to read more
23597
Related Questions
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?
Do you plan to use benralizumab to treat acute exacerbations of asthma or COPD associated with eosinophilia?
Is there any genetic testing available for the CDHR3 receptor?
Would you stop Dupixent in an asthma patient who has good asthma control and notes improvement in loss of smell, but shows notable eosinophil elevation after 4-5 doses of the medication?
If a child 4 years of age or younger has respiratory symptoms consistent with asthma, are you diagnosing asthma or using different terminology such as bronchiolitis or reactive airway disease?
What is your approach to distinguishing a Jarisch-Herxheimer reaction from a delayed anaphylactoid reaction?
Are there best practices for integrating pollen, wildfire smoke, and AQI data into asthma/allergic rhinitis action plans?
Do you generally favor nebulizers, HFAs or other devices in children aged 5 and younger with asthma?
Have you experienced any issues with Alvesco inhalers getting clogged repeatedly?
How do you approach hypogammaglobulinemia in a patient with sarcoidosis?